Online Only Articles

Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia

Syros Pharmaceuticals, Inc, Cambridge, MA, USA
Syros Pharmaceuticals, Inc, Cambridge, MA, USA
Syros Pharmaceuticals, Inc, Cambridge, MA, USA
Syros Pharmaceuticals, Inc, Cambridge, MA, USA
Syros Pharmaceuticals, Inc, Cambridge, MA, USA
Vol. 104 No. 4 (2019): April, 2019 https://doi.org/10.3324/haematol.2018.192807